The conclave will be inaugurated by Suchitra Ella, co-founder and managing director of Bharat Biotech, and CII-president designate. The programme will be presided over by G. Viswanathan, founder and chancellor of Vellore Institute of Technology (VIT). G. V. Selvam, Vice-President, VIT, will deliver the special address.
Speaking about the conclave, Mr. Selvam said, “Biotechnology represents one of the most consequential frontiers of education and research, with the power to improve lives and address some of society’s most urgent challenges. Through this conclave, VIT Chennai aims to encourage students to see biotechnology not only as a field of study, but as a pathway to innovation, enterprise and meaningful service to humanity.”
Ganapathy, honorary distinguished professor, IIM Jammu, distinguished professor, The Tamil Nadu Dr. M.G.R. Medical University and emeritus professor, National Academy of Medical Sciences; Mayur Abhaya, managing director, LifeCell International; and Shridevi S, deputy director, Centre for NeuroInformatics, VIT Chennai, will discuss the convergence of technology and biotechnology in conversation with Zubeda Hamid, senior assistant editor, The Hindu.
The panel on gene editing and precision medicine will focus on advances in genomics, clinical genetics and personalised healthcare. Vinod Scaria, chief data officer, Karkinos Healthcare; Kalpana Gowrishankar, clinical geneticist and counselor, Apollo Hospitals; and G. Jayaraman, dean, School of Bio Sciences and Technology, VIT Chennai, will discuss the movement of gene-based technologies from laboratories into clinical and public health contexts, in conversation with Geetha Srimathi. S, senior reporter, The Hindu.
A session on India’s emergence as a global biopharma hub will explore the country’s growing role in the global biopharmaceutical landscape and the opportunities shaping its future. Maneesh Paul, CEO, Microvioma, lead co-inventor and program director of the anti-infective Enmetazobactam, Orchid Pharma; Vasan Sambandamurthy, senior vice-president, Bugworks Research India Pvt Ltd; and M. M. Balamurali, Professor, Centre for Healthcare Advancement, Innovation and Research, VIT Chennai, will join Athira Elssa Johnson, senior reporter, The Hindu.
The funding landscape for biotech research in India will be explored by Ajay Mahipal, co-founder and general partner, HealthKois, in conversation with Serena Josephine M, special correspondent, The Hindu. The discussion will examine capital, institutional support and venture-building ecosystems.
The last session will feature K. VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, in conversation with Jacob Koshy, Science Editor, The Hindu. It will explore India’s research and innovation ecosystem, its evolution, key opportunities and the role it can play in shaping the future of biotechnology and life sciences.
The Biotech Conclave 2026 brings students into direct conversation with experts and thought leaders, offering them a closer look at the latest developments, emerging opportunities and diverse career pathways in biotechnology, spanning research, healthcare innovation, enterprise and public good.
To watch the event live
Scan the QR code or visit https://newsth.live/VITBTCLS
